“The Tan Sheet” readers also made top stories of FDA’s rejection of Bayer’s petition for aspirin as primary prevention of heart attack stroke; advisors recommending FDA consider additional label warnings for OTC NSAIDS; and FDA seeking to overhaul its OTC drug monograph process to be “more agile and responsive.”
Rx-to-OTC switch news could be a full meal for readers of “The Tan Sheet,” but those articles amount to appetizers for a plate of Johnson & Johnson OTC manufacturing history.
From the “The Tan Sheet” 2014 menu, readers selected more articles about OTC switches than any other topic. The news...